BDBM50085691 CHEMBL350109::N-Benzyl-2-(4-benzylsulfamoyl-2-nitro-phenylamino)-thioacetamide
SMILES: [O-][N+](=O)c1cc(ccc1NCC(=[SH+])[N-]Cc1ccccc1)S(=O)(=O)NCc1ccccc1
InChI Key: InChIKey=NFEYYZXNIXMHGZ-UHFFFAOYSA-N
Data: 1 KI
Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
BDKRB2 (RAT) | BDBM50085691 (CHEMBL350109 | N-Benzyl-2-(4-benzylsulfamoyl-2-nit...) | UniProtKB/SwissProt GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem | PubMed | >1.00E+5 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Novartis Institute for Medical Sciences Curated by ChEMBL | Assay Description Inhibition of binding of [3H]-BK to rat bradykinin B2 receptor expressed in NG108-15 neuroblastoma-glioma hybrid cell membranes | J Med Chem 43: 769-71 (2000) BindingDB Entry DOI: 10.7270/Q2XD10W5 | |||||||||||
More data for this Ligand-Target Pair |